| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/16/2006 | EP1084143B1 Purification process for production of mannan-binding lectin and an mbl medicinal product |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | EP1053324B1 Novel cystine knot protein and materials and methods for making it |
| 08/16/2006 | EP1032651B1 INDUCIBLE CELLULAR IMMUNITY THROUGH ACTIVATION OF Th1 AND SUPPRESSION OF Th2 RESPONSES BY MACROPHAGES |
| 08/16/2006 | EP1028729B1 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0977577B1 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant |
| 08/16/2006 | EP0972037B1 Beta-catenin, tcf-4, and apc interact to prevent cancer |
| 08/16/2006 | EP0827509B1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 08/16/2006 | EP0809655B1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION |
| 08/16/2006 | EP0784690B1 Complementary adenoviral vector systems and cell lines |
| 08/16/2006 | EP0314705B2 A novel family of primate hematopoietic growth factors |
| 08/16/2006 | CN1820200A Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/16/2006 | CN1820080A Product quality enhancement in mammalian cell culture processes for protein production |
| 08/16/2006 | CN1820075A Hepatitis B surface antigen blending gene and protein for carboxyl terminal containing precursor 32 immune decision cluster |
| 08/16/2006 | CN1820025A Fluorescein-labelled peptides |
| 08/16/2006 | CN1820024A Novel poly(ethylene glycol) modified compounds and uses thereof |
| 08/16/2006 | CN1820019A Antimicrobial polypeptides |
| 08/16/2006 | CN1820018A Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1819840A Use of inhibitors of enzymes with APN and/or DPIV activity and pharmaceutical preparations of said inhibitors for the treatment and prevention of dermatological diseases involving the hyperproliferati |
| 08/16/2006 | CN1819839A Immune-adjusting compound and relating method thereof |
| 08/16/2006 | CN1819838A Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells |
| 08/16/2006 | CN1819837A TAMANDARIN analogs and fragments thereof and methods of making and using |
| 08/16/2006 | CN1819834A Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections |
| 08/16/2006 | CN1819817A The solid dispersion of tacrolimus |
| 08/16/2006 | CN1819776A Process for producing liquid formulation containing raw yeast and liquid formulation |
| 08/16/2006 | CN1817909A Double-functional blended protein |
| 08/16/2006 | CN1817908A Recombinant solvent protein derivative, its production and use |
| 08/16/2006 | CN1817907A Recombinant solvent protein, its production and use |
| 08/16/2006 | CN1817904A Gerobriecin pancrease glucagon peptidel (SGLP-1), its preparation and use |
| 08/16/2006 | CN1817903A Phosphoinositolglycan (PIG)-binding protein from adipocytes |
| 08/16/2006 | CN1817901A Therapeutic peptides and method |
| 08/16/2006 | CN1817367A Activation and inhibition of the immune system |
| 08/16/2006 | CN1269960C Human FGF23 protein mutant lowering blood phosphorus level |
| 08/16/2006 | CN1269958C Zinc finger binding domains for GNN |
| 08/16/2006 | CN1269955C Manufacture of hemoglobin-based oxygen carrier |
| 08/16/2006 | CN1269839C Treatment with anti-ErbB2 antibodies |
| 08/16/2006 | CN1269838C Signal sequences for the production of Leu-hirudine via secretion by E. coli in a culture medium |
| 08/16/2006 | CN1269837C Serial synthetic antibacterial peptide |
| 08/16/2006 | CN1269817C Dehalogeno compounds |
| 08/16/2006 | CN1269801C Amino acid derivatives and drug containing the same as the active ingredient |
| 08/16/2006 | CN1269528C Application of dipeptide base peptidase IV effector for reducing blood sugar level of mammal |
| 08/16/2006 | CN1269527C Compound alliin powder injection |
| 08/16/2006 | CN1269526C Application of agglutinin II protein of rhizome of manyflower solmonaeal in preparation of pharmacy for treating or preventing hepatitis B |
| 08/16/2006 | CN1269525C Application of agglutinin II protein of rhizome of king solomonseal in preparation of medicine for treating or preventing bleb-caused diseases |
| 08/16/2006 | CN1269524C Thymosin augmentation of genetic immunization |
| 08/16/2006 | CN1269477C Inflammation-inhibiting compounds |
| 08/15/2006 | USRE39240 pure peptides which are highly selective for a specific human receptor; treatment of neuromuscular disorders, rapid reversible immobilization of muscles in vertebrate species; pesticide |
| 08/15/2006 | USRE39239 Methods for treating early morning pathologies |
| 08/15/2006 | USRE39238 Transgenic pathogen-resistant organism |
| 08/15/2006 | US7091372 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 08/15/2006 | US7091333 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases |
| 08/15/2006 | US7091331 Nucleic acid molecules and polypeptides encoding baboon TAFI |
| 08/15/2006 | US7091330 Cloning and characterization of a CD2 binding protein (CD2BP2) |
| 08/15/2006 | US7091329 Protein 68075 and its use for regenerating nerve cell processes |
| 08/15/2006 | US7091326 Fusion protein having enhanced in vivo erythropoietin activity |
| 08/15/2006 | US7091325 Fibrin/fibrinogen-binding conjugate |
| 08/15/2006 | US7091324 For diagnosis and therapy of HCV infection, including being useful in the identification of patients expected to benefit from certain therapeutic strategies |
| 08/15/2006 | US7091320 Product derived from milk substantially free of beta casein from non-human mammals and relative use |
| 08/15/2006 | US7091316 Protein induced by homogeneous blood transfusion and DNA encoding the same |
| 08/15/2006 | US7091315 heterologous polypeptide is the Fc domain of immunoglobulins, used to stimulate biosynthesis of interferons, or for diagnosis or prophylaxis of diseases; immunostimulants |
| 08/15/2006 | US7091314 Intermediates and methods for making heptapeptide oxytocin analogues |
| 08/15/2006 | US7091313 Coupling a solid support derived from polystyrene with N-protected derivative of amino acid, removing N-protecting group, coupling the product thus obtained with N-protected derivative of amino acid; removing protecting group, repeating the procedure, coupling, cyclization |
| 08/15/2006 | US7091311 Peptides and compounds that bind to a receptor |
| 08/15/2006 | US7091310 Chemokine analogs for the treatment of human disease |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091190 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/15/2006 | US7091185 Periodic antimicrobial peptides |
| 08/15/2006 | US7091184 Hepatitis C inhibitor tri-peptides |
| 08/15/2006 | US7091183 Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP) |
| 08/15/2006 | US7091182 Analyzing a blood sample for secretin level |
| 08/15/2006 | US7091181 Analgesics, antiinflammatory agents; mixture containing enzyme inhibitor |
| 08/15/2006 | US7091180 Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same |
| 08/15/2006 | US7091179 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease |
| 08/15/2006 | US7091176 Methods for treating arthritis pain |
| 08/15/2006 | US7091175 activating neovascularization by administering heptapeptides having replacements in the amino acid sequence; antiischemic agents; regeneration and maintenance of artificial bones |
| 08/15/2006 | US7091174 Caloxins |
| 08/15/2006 | US7091173 FAP48-interacting proteins and use thereof |
| 08/15/2006 | US7091047 Methods and kits for diagnosing tumorigenicity |
| 08/15/2006 | US7091040 P450/acetaminophen genetically directed enzyme prodrug therapy (GDEPT) |
| 08/15/2006 | US7091038 Ecdysone receptor-based inducible gene expression system |
| 08/15/2006 | US7091026 Synthetic peptide for use in the treatment of cancer, inflammation and infections |
| 08/15/2006 | US7091021 Inactive variants of the human telomerase catalytic subunit |
| 08/15/2006 | US7091018 Enzyme gene and its expression product |
| 08/15/2006 | US7091010 Biodegradable, resistant to salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics |
| 08/15/2006 | US7091007 Comprises nucleotide sequences coding bone morphogenic and serine/threonine receptor proteins for for identifying modulators for use in prevention and treatment of bone and/or cartilage disorders |
| 08/15/2006 | US7091005 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis or prevention of vision defects |
| 08/15/2006 | US7091000 Bacterial strains which overproduce riboflavin and methods of use thereof |
| 08/15/2006 | US7090989 Recombinant human SM-11044-binding receptor proteins exhibiting ligand-binding activities, and their uses |
| 08/15/2006 | US7090986 identifying compounds such as antibodies that compete with the binding of Saratin to collagen by determining the binding of said Saratin to collagen in the presence or absence of a competitor. |
| 08/15/2006 | US7090982 Mimetic polypeptide for treatment and prevention of nervous system disorders |
| 08/15/2006 | US7090971 identifying a compound capable of modulating trans-glutaminase (TG) kinase activity by determining if it activates or inhibits TG2 kinase activity as indicated by a TG2 mediated phosphorylation of the TG2 kinase |
| 08/15/2006 | US7090887 Oilseed processing |
| 08/15/2006 | US7090869 Suppressing the instant release or denaturation of active material, by mixing with a biodegradable polymer, solidification with high-pressure gas; drug delivery, sustained releasing growth hormone, candesartan |
| 08/15/2006 | US7090864 Non-invasive gene targeting to ocular cells |
| 08/15/2006 | US7090861 Sustained release delivery systems for solutes |
| 08/15/2006 | US7090858 Coated filter bag material for oral administration of medicament in liquid and methods of making same |
| 08/15/2006 | US7090852 Virion protein; induce immunology response; genetic engineered Dna |
| 08/15/2006 | US7090850 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |